Medical Developments International Limited (MDDVF)
Medical Developments International Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Scoresby, VIC, AU. The stock last traded at $0.32, up 0.00% on the session, giving a market capitalisation of $35.8M. On trailing twelve-month figures it carries a trailing P/E of 79.46, a net margin of 1.5%. Its beta of 1.41 implies it has historically moved more than the broad market.
Medical Developments International Limited is a global provider of essential medical solutions, engaged in both their manufacturing and distribution. The company's reach extends throughout Australia, Europe, the United States, and other international markets, with its operations divided into two primary segments: Pain Management and Respiratory. Within its respiratory division, it develops devices to assist individuals afflicted with conditions such as asthma and chronic obstructive pulmonary disease. For pain relief, a cornerstone product is Penthrox, utilized in trauma and emergency scenarios. Furthermore, Medical Developments International offers a diverse selection of medical instruments, including CPR equipment like face shield keyrings and masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, and various oxygen therapy and resuscitation kits and masks. Founded in 2003, the company's main office is located in Scoresby, Australia.
Medical Developments International Limited is most often compared with the following Healthcare names: